2Young JB,Hauptam PJ,Naftel DC,et al.Determinants of early graft failure following cardiac transplantation,a 10 year multi-institutional.Multivarialbe analysis.J Heart Lung Transplant 2001,20:212.
3Kirklin JW,Naftel DC.Pulmonary vascular resistance and the risk of heart transplantation.J Heart Transplant,1988,7,331-336.
4Costared-Hackle A,Schroeder JS,Folwer MB.The influence of preoperative patient characteristics on early and late survival following cardiac transplantation.Circulation,1991,84(Suppl 3):329-337.
5Miller LW,Naftel DC,Bourge RC,et al.Infection after heart transplantation:a multiinstitutional study.J Heart Lung Transplant,1994,13:381 -393.(Reid KR,Menkis AH,Novick RJ,et al.Redued incidence of severe infection after heart transplantation with low intensity immunosuppression,J Heart Lung Transplant 1991:10:894-900).
6Ray JE,Keogh AM.Cyclosporin C2 and C0 concertration monitoring in stable,long-term heart transplant recipients receiving metabolic inhibitors.J Heart Lung Transplat,2003,22:715.
7Kirklin JK,Naftel DC,Bourge RC,et al.Rejection after cardiac transplantation.Circulation,1992,86S:236-241.
8Bourge RC,Naftel DC,Hill RA,et al.The emergence of co-morbid diseases impacting survival after cardiac transplantation:a ten year multi-institutional experience.J Heart Lung Transplant,2001,20:167.
